Chemical Structure : dCDK9-202
货号: PC-25872Not For Human Use, Lab Use Only.
dCDK9-202 is a highly potent, selective PROTAC CDK9 degrader with DC50 of 3.5 nM and CDK9 decline (94.4%) at 25 nM in TC-71 cell line, inhibits cell growth with IC50 of 8.5 nM in TC-71 cells.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
dCDK9-202 is a highly potent, selective PROTAC CDK9 degrader with DC50 of 3.5 nM and CDK9 decline (94.4%) at 25 nM in TC-71 cell line, inhibits cell growth with IC50 of 8.5 nM in TC-71 cells.
dCDK9-202 is highly selective in the degradation of CDK9 among the CDK protein family, as well as IKZF.
dCDK9-202 depletes significantly endogenous CDK9 within 25 nM in U87 glioblastoma cells, SKUT1 uterine leiomyosarcoma cells, and RH5 rhabdomyosarcoma cells with DC50 values lower than 10 nM.
dCDK9-202 is capable of inhibiting cell proliferation and inducing apoptosis.
dCDK9-202 exhibits antiproliferative inhibition against multiple cancer cell lines (IC50=40.9 nM for T778 cell line, 79.6 nM for MDA-MB-231 cell line.
dCDK9-202 selectively proteolyzes CDK9 to impair Pol2 function and cancer-addicted transcriptome.
dCDK9-202 (10 mg/kg over a 12 day treatment) significantly inhibited xenograft growth in TC-71 xenograft model in immunocompromised mice.
| 分子量 | 803.99 | |
| 分子式 | C40H49N7O7S2 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Ma L, et al. J Med Chem. 2025 Oct 23;68(20):21172-21186.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright